中核集团首个核医疗示范基地启用

Core Viewpoint - The inauguration of the Suzhou University Affiliated Second Hospital (Nuclear Industry General Hospital) marks a significant advancement in nuclear medical technology and its application in China, focusing on precision diagnosis and treatment, clinical trials, and medical innovation [1] Group 1: Project Overview - The Nuclear Industry General Hospital's Huguan Phase II project is a key engineering initiative by China National Nuclear Corporation (CNNC) and a major livelihood project for Suzhou [1] - The project integrates four core functions: precision diagnosis and treatment using nuclear technology, clinical trials, medical innovation, and training and communication [1] Group 2: Objectives and Impact - The aim is to enhance the capabilities for preventing and treating major diseases and improve nuclear emergency medical rescue capabilities in China [1] - The demonstration base is expected to drive independent innovation in nuclear medical technology and promote collaborative development within the industry [1] Group 3: Additional Initiatives - On the same day, CNNC launched the Nuclear Industry General Hospital - CNNC Particle SPET/CT clinical trial project and the IAEA tumor radiotherapy quality assurance team regional training project [1] - The establishment of the Nuclear Technology Medical Application Scenario Innovation Promotion Center and the Jiangsu Provincial Engineering Research Center, based on the Nuclear Industry General Hospital, signifies important progress in the integration of nuclear technology in medical applications [1]